Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
TripleMed logo — Creating minimally invasive solutions for aneurysms, providi...

TripleMed

Creating minimally invasive solutions for aneurysms, providing a seamless blood flow to other arteries for a longer-lasting treatment.

Founded 2011 Series A Total: $2.00M Biotechnology, Health Care

General Information

Company Name TripleMed
Founded Year 2011
Industries Biotechnology, Health Care
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with TripleMed. To contact TripleMed, visit triplemedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does TripleMed compare?

A PDF of TripleMed and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting TripleMed soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About TripleMed

TripleMed is a biotechnology startup founded in 2011 with a focus on creating minimally invasive solutions for aneurysms. Their slogan emphasizes the goal of providing a seamless blood flow to other arteries for a longer-lasting treatment. The company's description highlights their innovative approach, as they aim to eliminate the need for incisions with their initial product, which not only fills the aneurysm, blocking blood entry, but also maintains a channel for blood flow to surrounding arteries. This offers a superior and enduring answer to aortic aneurysms. In September 2017, TripleMed secured a €2.00M Series A investment from Chemelot Ventures and the Limburg Business Development Fund (LBDF). This investment not only reflects confidence in the startup's potential but also provides them with the necessary resources to further develop their groundbreaking solutions. TripleMed's focus on minimally invasive treatments aligns with the growing demand for advanced healthcare technologies, positioning them at the forefront of innovation in the healthcare industry.

Business keywords: minimally invasive surgery, aneurysm treatment, vascular health, interventional cardiology, medical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €2.00M 2
Chemelot Ventures
Chemelot Ventures, Limburg Business Development Fund (LBDF)
18 Sep 2017

TripleMed Alternatives & Competitors

View All Alternatives
TripleMed vs
Centerline Biomedical
Centerline Biomedical United States

A New Way to Envision Interventional Navigation

Series B
45 employees
Biotechnology, Health Care
TripleMed vs
Vena Medical
Vena Medical Canada

Vena Medical | The Vena Microcatheter

Seed
25 employees
Biotechnology, Health Care
TripleMed vs
Microport Urocare
Microport Urocare China

The Patient Always Comes First

Post-IPO Equity
10 employees
Biotechnology, Health Care
View all alternatives

FAQ About TripleMed

Creating minimally invasive solutions for aneurysms, providing a seamless blood flow to other arteries for a longer-lasting treatment.
TripleMed was founded in 2011.
TripleMed operates in Biotechnology and Health Care. Its work centres on minimally invasive surgery, aneurysm treatment, vascular health and interventional cardiology.
TripleMed has completed 1 funding round, raising a total of $2.00M. The latest funding stage is Series A.
Top alternatives and competitors to TripleMed include Centerline Biomedical, Vena Medical, Microport Urocare, NICO Corporation, Interventional Spine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TripleMed and Centerline Biomedical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TripleMed, https://bouncewatch.com/company/triplemed, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes